^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CART22

i
Associations
Company:
University of Pennsylvania
Drug class:
CD22-targeted CAR-T immunotherapy
Related drugs:
Associations
Phase 1
University of Pennsylvania
Active, not recruiting
Last update posted :
05/24/2024
Initiation :
09/27/2018
Primary completion :
01/01/2036
Completion :
01/01/2036
CD22
|
CD22 expression
|
CART22 • huCART19
Phase 1
University of Pennsylvania
Recruiting
Last update posted :
02/05/2024
Initiation :
01/13/2016
Primary completion :
12/01/2037
Completion :
12/01/2037
CD22
|
CD22 expression
|
CART22
Phase 1/2
Stephan Grupp MD PhD
Recruiting
Last update posted :
12/19/2023
Initiation :
01/25/2023
Primary completion :
01/15/2027
Completion :
01/15/2029
CD22
|
CD19 expression • CD22 expression
|
Kymriah (tisagenlecleucel-T) • CART22 • huCART19